RADIOPHARM THERANOSTICS LIMITED - Announcements

Market Cap $60.84M Add to my watchlist

Healthcare Biotechnology

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

RAD	RAD 502 can halt tumour progression and prolong survival	PRICE SENSITIVE	05/02/24	308.3KB	Share
RAD	Application for quotation of securities - RAD		31/01/24	25.09KB	Share
RAD	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/24	325.51KB	Share
RAD	Investor Presentation		24/01/24	1.54MB	Share
RAD	Placement of Entitlement Offer Shortfall	PRICE SENSITIVE	24/01/24	214.49KB	Share
RAD	Notice Under Section 708A		05/01/24	123.87KB	Share
RAD	Application for quotation of securities - RAD		05/01/24	25.53KB	Share
RAD	2nd Australian site for Nanomab-PDL-1 Phase 1 trial	PRICE SENSITIVE	27/12/23	303.62KB	Share
RAD	Notification regarding unquoted securities - RAD		22/12/23	23.81KB	Share
RAD	Phase 1 Therapeutic NSCLC (Lung Cancer) Trial Opens 4 Jan	PRICE SENSITIVE	22/12/23	268.51KB	Share
RAD	Change of Director's Interest Notice x5		15/12/23	339.11KB	Share
RAD	Notice Under Section 708A		15/12/23	123.77KB	Share
RAD	Application for quotation of securities - RAD		15/12/23	25.49KB	Share
RAD	Application for quotation of securities - RAD		08/12/23	25.05KB	Share
RAD	Completion of Entitlement Offer	PRICE SENSITIVE	08/12/23	162.94KB	Share
RAD	Change of Director's Interest Notice - PH IT RC		07/12/23	401.54KB	Share
RAD	Notification regarding unquoted securities - RAD		01/12/23	27.06KB	Share
RAD	Application for quotation of securities - RAD		24/11/23	25.21KB	Share
RAD	Amended Constitution		22/11/23	594.02KB	Share
RAD	Radiopharm receives $4.85M R&D tax incentive	PRICE SENSITIVE	21/11/23	148.63KB	Share
RAD	Update - Proposed issue of securities - RAD		21/11/23	28.34KB	Share
RAD	Entitlement Offer closing date extended to 1 December 2023		21/11/23	136.94KB	Share
RAD	Notification of Release of Shares from Escrow		16/11/23	145.03KB	Share
RAD	Results of Annual General Meeting		16/11/23	127.94KB	Share
RAD	Presentation to Annual General Meeting		16/11/23	737.12KB	Share
RAD	Bell Potter Healthcare Conference Presentation		15/11/23	1.62MB	Share
RAD	Entitlement Offer Documents	PRICE SENSITIVE	08/11/23	5.39MB	Share
RAD	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/23	1.47MB	Share
RAD	Entitlement Offer cleansing notice under section 708AA		31/10/23	211.73KB	Share
RAD	Proposed issue of securities - RAD		31/10/23	24.47KB	Share
RAD	Investor webinar		31/10/23	131.08KB	Share
RAD	Proposed issue of securities - RAD		31/10/23	28.68KB	Share
RAD	Investor Presentation - Entitlement Offer		31/10/23	1.56MB	Share
RAD	Entitlement Offer to raise approximately $10 million	PRICE SENSITIVE	31/10/23	228.3KB	Share
RAD	Notice of Annual General Meeting/Proxy Form		18/10/23	500.73KB	Share
RAD	FDA green light for diagnostic Phase 1 pancreatic trial	PRICE SENSITIVE	17/10/23	178.96KB	Share
RAD	RAD receives approval for Phase 1 therapeutic study of NSCLC	PRICE SENSITIVE	09/10/23	134.02KB	Share
RAD	ESG Report		28/09/23	1.07MB	Share
RAD	Appendix 4G		28/09/23	332.93KB	Share
RAD	Corporate Governance Statement		28/09/23	888.09KB	Share
RAD	Annual Report to shareholders		28/09/23	1.82MB	Share
RAD	Appendix 4E and FY23 Financial Report	PRICE SENSITIVE	31/08/23	1.79MB	Share
RAD	TerThera Terbium-161 isotope supply agreement expanded	PRICE SENSITIVE	24/08/23	220.37KB	Share
RAD	Results of Meeting		18/08/23	121.18KB	Share
RAD	EGM Presentation		18/08/23	364.99KB	Share
RAD	Change of Director's Interest Notice IT		08/08/23	175.8KB	Share
RAD	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/23	1.33MB	Share
RAD	Dr Sherin Al-Safadi appointed VP Medical & Corporate Affairs		24/07/23	132.41KB	Share
RAD	Notice of Extraordinary General Meeting/Proxy Form		20/07/23	383.69KB	Share
RAD	Notification of cessation of securities - RAD		30/06/23	21.85KB	Share
RAD	Notification regarding unquoted securities - RAD		30/06/23	25.26KB	Share
RAD	Pivalate educational webinar 14 June 2023		13/06/23	134.24KB	Share
RAD	FDA Pre-IND meeting supports an IND application for RAD 101	PRICE SENSITIVE	29/05/23	132.08KB	Share
RAD	RAD 301 receives FDA Orphan Drug Designation	PRICE SENSITIVE	09/05/23	227.82KB	Share
RAD	Application for quotation of securities - RAD		28/04/23	26.55KB	Share
RAD	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/04/23	1.46MB	Share
RAD	Agreement with TerThera to supply Terbium-161 isotope	PRICE SENSITIVE	17/04/23	234.32KB	Share
RAD	Radiopharm Receives $1.56M R&D Tax Incentive		28/03/23	150.14KB	Share
RAD	Radiopharm to participate in Jefferies Radiopharma Summit		28/03/23	152KB	Share
RAD	RAD and GenesisCare to Develop Novel Radiopharmaceuticals		27/03/23	197.97KB	Share
RAD	RAD to present at virtual healthcare conference		17/03/23	130.43KB	Share
RAD	Notice Under Section 708A		06/03/23	124.03KB	Share
RAD	Application for quotation of securities - RAD		06/03/23	25.17KB	Share
RAD	Dr Ken Herrmann appointed to RAD Scientific Advisory Board		03/03/23	110.69KB	Share
RAD	Radiopharm to acquire Pharma15 Corporation	PRICE SENSITIVE	03/03/23	152.64KB	Share
RAD	Proposed issue of securities - RAD		03/03/23	24.82KB	Share
RAD	Appendix 4D and Half Year Report	PRICE SENSITIVE	28/02/23	1.56MB	Share
RAD	Notification regarding unquoted securities - RAD		14/02/23	25.06KB	Share
RAD	Radiopharm Theranostics initiates process for Nasdaq listing	PRICE SENSITIVE	14/02/23	209.93KB	Share
RAD	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/23	2.19MB	Share
RAD	Dr. Rama Abu Shmeis appointed Senior VP, CMC		11/01/23	135.4KB	Share
RAD	Change in substantial holding - NT		06/01/23	751.89KB	Share
RAD	aVb6 Integrin (RAD301) IND approval for Phase 1 trial	PRICE SENSITIVE	30/12/22	140.65KB	Share
RAD	RAD201 HER2 nanobody demonstrates favourable tumor targeting		13/12/22	132.23KB	Share
RAD	Change in substantial holding - PH		09/12/22	245.73KB	Share
RAD	Change of Director's Interest Notice - PH		09/12/22	173.12KB	Share
RAD	Change of Director's Interest Notice - RC		09/12/22	173.08KB	Share
RAD	Change of Director's Interest Notice - IT		09/12/22	172.68KB	Share
RAD	Change of Director's Interest Notice - LA		09/12/22	171.86KB	Share
RAD	Change of Director's Interest Notice - HL		09/12/22	172.54KB	Share
RAD	Notification regarding unquoted securities - RAD		06/12/22	33.02KB	Share
RAD	Change of Director's Interest Notice - MB		02/12/22	192.92KB	Share
RAD	Change of Director's Interest Notice - IT		01/12/22	193.53KB	Share
RAD	Change of Director's Interest Notice - RC		29/11/22	171.93KB	Share
RAD	Change of Director's Interest Notice - PH		29/11/22	171.84KB	Share
RAD	Security Class Reinstatement to Quotation	PRICE SENSITIVE	28/11/22	86.74KB	Share
RAD	Notice Under Section 708A		25/11/22	123.4KB	Share
RAD	Application for quotation of securities - RAD		25/11/22	25.54KB	Share
RAD	Top Holders Report RADO Options		25/11/22	72.25KB	Share
RAD	Appendix 2A		25/11/22	377.1KB	Share
RAD	Additional data released from brain metastases imaging trial		23/11/22	898.91KB	Share
RAD	Successful completion of Retail Entitlement Offer		22/11/22	137.96KB	Share
RAD	RAD agreement with ANSTO to supply key isotope lutetium-177		22/11/22	156.71KB	Share
RAD	Security Class Suspension from Quotation RADO	PRICE SENSITIVE	21/11/22	88.79KB	Share
RAD	Application for quotation of securities - RAD		18/11/22	24.4KB	Share
RAD	Results of Annual General Meeting		16/11/22	564.43KB	Share
RAD	AGM Presentation		16/11/22	1.13MB	Share
RAD	AGM ATTENDANCE		08/11/22	145.63KB	Share
RAD	Notification of Release of Shares from Escrow		08/11/22	145.48KB	Share
RAD	Update - Proposed issue of securities		08/11/22	697.49KB	Share

RAD RAD 502 can halt tumour progression and prolong survival
05/02/24	PRICE SENSITIVE	308.3KB	Share
RAD Application for quotation of securities - RAD
31/01/24		25.09KB	Share
RAD Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24	PRICE SENSITIVE	325.51KB	Share
RAD Investor Presentation
24/01/24		1.54MB	Share
RAD Placement of Entitlement Offer Shortfall
24/01/24	PRICE SENSITIVE	214.49KB	Share
RAD Notice Under Section 708A
05/01/24		123.87KB	Share
RAD Application for quotation of securities - RAD
05/01/24		25.53KB	Share
RAD 2nd Australian site for Nanomab-PDL-1 Phase 1 trial
27/12/23	PRICE SENSITIVE	303.62KB	Share
RAD Notification regarding unquoted securities - RAD
22/12/23		23.81KB	Share
RAD Phase 1 Therapeutic NSCLC (Lung Cancer) Trial Opens 4 Jan
22/12/23	PRICE SENSITIVE	268.51KB	Share
RAD Change of Director's Interest Notice x5
15/12/23		339.11KB	Share
RAD Notice Under Section 708A
15/12/23		123.77KB	Share
RAD Application for quotation of securities - RAD
15/12/23		25.49KB	Share
RAD Application for quotation of securities - RAD
08/12/23		25.05KB	Share
RAD Completion of Entitlement Offer
08/12/23	PRICE SENSITIVE	162.94KB	Share
RAD Change of Director's Interest Notice - PH IT RC
07/12/23		401.54KB	Share
RAD Notification regarding unquoted securities - RAD
01/12/23		27.06KB	Share
RAD Application for quotation of securities - RAD
24/11/23		25.21KB	Share
RAD Amended Constitution
22/11/23		594.02KB	Share
RAD Radiopharm receives $4.85M R&D tax incentive
21/11/23	PRICE SENSITIVE	148.63KB	Share
RAD Update - Proposed issue of securities - RAD
21/11/23		28.34KB	Share
RAD Entitlement Offer closing date extended to 1 December 2023
21/11/23		136.94KB	Share
RAD Notification of Release of Shares from Escrow
16/11/23		145.03KB	Share
RAD Results of Annual General Meeting
16/11/23		127.94KB	Share
RAD Presentation to Annual General Meeting
16/11/23		737.12KB	Share
RAD Bell Potter Healthcare Conference Presentation
15/11/23		1.62MB	Share
RAD Entitlement Offer Documents
08/11/23	PRICE SENSITIVE	5.39MB	Share
RAD Quarterly Activities/Appendix 4C Cash Flow Report
31/10/23	PRICE SENSITIVE	1.47MB	Share
RAD Entitlement Offer cleansing notice under section 708AA
31/10/23		211.73KB	Share
RAD Proposed issue of securities - RAD
31/10/23		24.47KB	Share
RAD Investor webinar
31/10/23		131.08KB	Share
RAD Proposed issue of securities - RAD
31/10/23		28.68KB	Share
RAD Investor Presentation - Entitlement Offer
31/10/23		1.56MB	Share
RAD Entitlement Offer to raise approximately $10 million
31/10/23	PRICE SENSITIVE	228.3KB	Share
RAD Notice of Annual General Meeting/Proxy Form
18/10/23		500.73KB	Share
RAD FDA green light for diagnostic Phase 1 pancreatic trial
17/10/23	PRICE SENSITIVE	178.96KB	Share
RAD RAD receives approval for Phase 1 therapeutic study of NSCLC
09/10/23	PRICE SENSITIVE	134.02KB	Share
RAD ESG Report
28/09/23		1.07MB	Share
RAD Appendix 4G
28/09/23		332.93KB	Share
RAD Corporate Governance Statement
28/09/23		888.09KB	Share
RAD Annual Report to shareholders
28/09/23		1.82MB	Share
RAD Appendix 4E and FY23 Financial Report
31/08/23	PRICE SENSITIVE	1.79MB	Share
RAD TerThera Terbium-161 isotope supply agreement expanded
24/08/23	PRICE SENSITIVE	220.37KB	Share
RAD Results of Meeting
18/08/23		121.18KB	Share
RAD EGM Presentation
18/08/23		364.99KB	Share
RAD Change of Director's Interest Notice IT
08/08/23		175.8KB	Share
RAD Quarterly Activities/Appendix 4C Cash Flow Report
31/07/23	PRICE SENSITIVE	1.33MB	Share
RAD Dr Sherin Al-Safadi appointed VP Medical & Corporate Affairs
24/07/23		132.41KB	Share
RAD Notice of Extraordinary General Meeting/Proxy Form
20/07/23		383.69KB	Share
RAD Notification of cessation of securities - RAD
30/06/23		21.85KB	Share
RAD Notification regarding unquoted securities - RAD
30/06/23		25.26KB	Share
RAD Pivalate educational webinar 14 June 2023
13/06/23		134.24KB	Share
RAD FDA Pre-IND meeting supports an IND application for RAD 101
29/05/23	PRICE SENSITIVE	132.08KB	Share
RAD RAD 301 receives FDA Orphan Drug Designation
09/05/23	PRICE SENSITIVE	227.82KB	Share
RAD Application for quotation of securities - RAD
28/04/23		26.55KB	Share
RAD Quarterly Activities/Appendix 4C Cash Flow Report
27/04/23	PRICE SENSITIVE	1.46MB	Share
RAD Agreement with TerThera to supply Terbium-161 isotope
17/04/23	PRICE SENSITIVE	234.32KB	Share
RAD Radiopharm Receives $1.56M R&D Tax Incentive
28/03/23		150.14KB	Share
RAD Radiopharm to participate in Jefferies Radiopharma Summit
28/03/23		152KB	Share
RAD RAD and GenesisCare to Develop Novel Radiopharmaceuticals
27/03/23		197.97KB	Share
RAD RAD to present at virtual healthcare conference
17/03/23		130.43KB	Share
RAD Notice Under Section 708A
06/03/23		124.03KB	Share
RAD Application for quotation of securities - RAD
06/03/23		25.17KB	Share
RAD Dr Ken Herrmann appointed to RAD Scientific Advisory Board
03/03/23		110.69KB	Share
RAD Radiopharm to acquire Pharma15 Corporation
03/03/23	PRICE SENSITIVE	152.64KB	Share
RAD Proposed issue of securities - RAD
03/03/23		24.82KB	Share
RAD Appendix 4D and Half Year Report
28/02/23	PRICE SENSITIVE	1.56MB	Share
RAD Notification regarding unquoted securities - RAD
14/02/23		25.06KB	Share
RAD Radiopharm Theranostics initiates process for Nasdaq listing
14/02/23	PRICE SENSITIVE	209.93KB	Share
RAD Quarterly Activities/Appendix 4C Cash Flow Report
31/01/23	PRICE SENSITIVE	2.19MB	Share
RAD Dr. Rama Abu Shmeis appointed Senior VP, CMC
11/01/23		135.4KB	Share
RAD Change in substantial holding - NT
06/01/23		751.89KB	Share
RAD aVb6 Integrin (RAD301) IND approval for Phase 1 trial
30/12/22	PRICE SENSITIVE	140.65KB	Share
RAD RAD201 HER2 nanobody demonstrates favourable tumor targeting
13/12/22		132.23KB	Share
RAD Change in substantial holding - PH
09/12/22		245.73KB	Share
RAD Change of Director's Interest Notice - PH
09/12/22		173.12KB	Share
RAD Change of Director's Interest Notice - RC
09/12/22		173.08KB	Share
RAD Change of Director's Interest Notice - IT
09/12/22		172.68KB	Share
RAD Change of Director's Interest Notice - LA
09/12/22		171.86KB	Share
RAD Change of Director's Interest Notice - HL
09/12/22		172.54KB	Share
RAD Notification regarding unquoted securities - RAD
06/12/22		33.02KB	Share
RAD Change of Director's Interest Notice - MB
02/12/22		192.92KB	Share
RAD Change of Director's Interest Notice - IT
01/12/22		193.53KB	Share
RAD Change of Director's Interest Notice - RC
29/11/22		171.93KB	Share
RAD Change of Director's Interest Notice - PH
29/11/22		171.84KB	Share
RAD Security Class Reinstatement to Quotation
28/11/22	PRICE SENSITIVE	86.74KB	Share
RAD Notice Under Section 708A
25/11/22		123.4KB	Share
RAD Application for quotation of securities - RAD
25/11/22		25.54KB	Share
RAD Top Holders Report RADO Options
25/11/22		72.25KB	Share
RAD Appendix 2A
25/11/22		377.1KB	Share
RAD Additional data released from brain metastases imaging trial
23/11/22		898.91KB	Share
RAD Successful completion of Retail Entitlement Offer
22/11/22		137.96KB	Share
RAD RAD agreement with ANSTO to supply key isotope lutetium-177
22/11/22		156.71KB	Share
RAD Security Class Suspension from Quotation RADO
21/11/22	PRICE SENSITIVE	88.79KB	Share
RAD Application for quotation of securities - RAD
18/11/22		24.4KB	Share
RAD Results of Annual General Meeting
16/11/22		564.43KB	Share
RAD AGM Presentation
16/11/22		1.13MB	Share
RAD AGM ATTENDANCE
08/11/22		145.63KB	Share
RAD Notification of Release of Shares from Escrow
08/11/22		145.48KB	Share
RAD Update - Proposed issue of securities
08/11/22		697.49KB	Share

REFRESH

First 2 3

(20min delay)
Last 2.8¢		Change 0.000(0.00%)		Mkt cap ! $60.84M

Open	High	Low	Value	Volume
2.9¢	2.9¢	2.7¢	$117.3K	4.225M

Buyers (Bids)

No.	Vol.	Price($)
3	979009	2.8¢

Sellers (Offers)

Price($)	Vol.	No.
2.9¢	300000	1

View Market Depth

No.	Vol.	Price($)
3	979009	0.028
12	2375326	0.027
8	1059149	0.026
4	890000	0.025
2	110000	0.024

Price($)	Vol.	No.
0.029	300000	1
0.030	200000	2
0.031	789676	3
0.032	400000	1
0.033	484083	2

Last trade - 16.10pm 02/10/2024 (20 minute delay)


Last 2.8¢		Change 0.000 ( 0.00 %)
Open	High	Low	Volume
2.9¢	2.9¢	2.7¢	801448
Last updated 15.56pm 02/10/2024 ?

RAD (ASX) Chart

RADIOPHARM THERANOSTICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available